The Mediator is an evolutionarily conserved, multi-subunit complex that regulates multiple steps of transcription. Mediator activity is regulated by the reversible association of a four-subunit module comprising CDK8 or CDK19 kinases, together with cyclin C, MED12 or MED12L, and MED13 or MED13L. Mutations in MED12, MED13, and MED13L were previously identified in syndromic developmental disorders with overlapping phenotypes. Here, we report CDK8 mutations (located at 13q12.13) that cause a phenotypically related disorder. Using whole-exome or whole-genome sequencing, and by international collaboration, we identified eight different heterozygous missense CDK8 substitutions, including 10 shown to have arisen de novo, in 12 unrelated subjects; a recurrent mutation, c.185C>T (p.Ser62Leu), was present in five individuals. All predicted substitutions localize to the ATP-binding pocket of the kinase domain. Affected individuals have overlapping phenotypes characterized by hypotonia, mild to moderate intellectual disability, behavioral disorders, and variable facial dysmorphism. Congenital heart disease occurred in six subjects; additional features present in multiple individuals included agenesis of the corpus callosum, ano-rectal malformations, seizures, and hearing or visual impairments. To evaluate the functional impact of the mutations, we measured phosphorylation at STAT1-Ser727, a known CDK8 substrate, in a CDK8 and CDK19 CRISPR double-knockout cell line transfected with wild-type (WT) or mutant CDK8 constructs. These experiments demonstrated a reduction in STAT1 phosphorylation by all mutants, in most cases to a similar extent as in a kinase-dead control. We conclude that missense mutations in CDK8 cause a developmental disorder that has phenotypic similarity to syndromes associated with mutations in other subunits of the Mediator kinase module, indicating probable overlap in pathogenic mechanisms.
In humans, mutations in the genes (MED12, MED13, and MED13L) encoding subunits of the Module have been implicated in developmental disorders. Mutations in the X-linked MED12 (MIM: 300188) cause at least three different syndromes: Opitz-Kaveggia syndrome (also known as FG syndrome; MIM: 305450), Lujan-Fryns syndrome (MIM: 309520), and Ohdo syndrome (MIM: 300895). These syndromes have partly overlapping clinical features, including multiple congenital defects, facial dysmorphic features, hypotonia, behavioral problems, and intellectual disability (ID). 6 Mutations in MED13L (MIM:
608771) are associated with a syndromic form of ID (MIM: 616789) characterized by facial dysmorphism, ID, speech impairment, motor developmental delay with muscular hypotonia, cardiac anomalies, and behavioral difficulties. 7, 8 Recently, mutations in MED13 (MIM:
603808) have been reported as leading to a neurodevelopmental disorder characterized by ID and/or developmental delay, including speech delay; additional features that were present in two or more affected individuals included autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), optic nerve abnormalities, Duane anomaly, hypotonia, mild congenital heart abnormalities, and dysmorphic features. 9 Here, using whole-exome or whole-genome sequencing and by international collaboration, we report de novo mutations in CDK8, which has not been previously associated with a congenital disorder, in 12 unrelated individuals with overlapping phenotypes. The study was initiated as part of a whole-genome sequencing (WGS)-based investigation of craniosynostosis in the Netherlands after approval by the board of the medical ethical committee Rotterdam (MEC-2012-140). Written informed consent was obtained from all participants or their legal guardians. Parent-child trio-based WGS of a proband with metopic synostosis and ID (subject 3 in Table 1 ) identified a de novo c.88G>A transition in CDK8; this change leads to the prediction of a heterozygous p.Gly30Ser substitution. The position of this substitution, at an almost invariant residue within the highly conserved glycine-rich loop of the kinase domain, 9 and in which pathogenic mutations were previously identified in other protein kinases, 22, 57 led us to seek evidence for additional pathogenic variants in CDK8 through GeneMatcher exchange 10 and from the Deciphering Developmental Disorders (DDD) research study. 11 The DDD study has UK research ethics committee (REC) approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). Details of the methodology we used to identify each mutation (wholeexome sequencing [WES] in every instance except the original index subject) are provided in the Supplemental Material and Methods. By these means, we identified a further 11 unrelated individuals harboring eight different nucleotide substitutions within CDK8; one substitution (c.185C>T encoding p.Ser62Leu) was present in five subjects ( Figure 2A and Table 1 ). All CDK8 variants were constitutionally absent from the ExAC and gnomAD databases of common variation (accessed November 2018).
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CDK8 is a gene that comprises 13 exons; it is located at chromosomal region 13q12.13 and encodes a major isoform of 464 amino acids. All seven unique substitutions, and three of five instances of p.Ser62Leu, arose de novo from unaffected parents who had correct paternity confirmed either by comparison of trio-WES or WGS data or by microsatellite analysis; paternal samples were unavailable in the remaining two cases (the recurrence of the c.185C>T transition is likely to be explained by its position in a hypermutable CpG dinucleotide). The eight substituted amino acids are all located within the kinase domain, which extends between amino acids 21-335 ( Figure 2B ), and they are invariant in a wide range of vertebrate CDK8 orthologs, as well as in the human paralog CDK19; in six cases, this invariance extends to the invertebrates Drosophila, Aedes, and Caenorhabditis ( Figure 2C ). MutationTaster predicted all eight substitutions to be disease-causing, and SIFT and PolyPhen-2 predicted all to Figure 1 . Simplified Illustration of the Mediator Complex and the RNA Pol II Machinery at the Promoter of a Hypothetical Gene The CDK8 or CDK19 kinase Module (orange) reversibly binds the Mediator complex to regulate its activity. The Mediator complex (head in blue, middle in green, and tail in purple; additional subunits in light gray) bridges between genespecific activators (dark gray) that are bound to regulatory elements (RE) and general transcription machinery that comprises the RNA pol II (brown) and general transcription factors (yellow). The DNA molecule cartoon was obtained from the Servier Medical Art; the representation was adapted from Larivière et al. 
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Brain MRI or CT normal thin corpus callosum normal ACC NA ACC NA ACC non-specific NA normal NA Ophthalmic: ptosis be damaging with the exception of the c.291T>G (p.Phe97Leu) variant (Table S1 ). CDK8 is intolerant to missense variants (z ¼ 3.81, observed/expected ratio ¼ 0.34; gnomAD database) 12 and exhibits high constraint throughout the protein. 13 On the basis of the DOMINO algorithm, CDK8 was predicted to be among the top candidate genes for which mutations are likely to manifest with a dominant pattern of inheritance. 14 The clustering of multiple de novo substitutions localized to a single, highly conserved domain of the protein provides a strong pathogenicity signature, as has been described for several other genes including the cyclin-dependent kinase (CDK)-encoding CDK13. 11, 15, 16 We assessed the phenotypes of the 12 subjects, seven males and five females aged 0.1-16.7 years at the last clinical assessment, with CDK8 substitutions by using a standardized spreadsheet-based questionnaire (summarized in Table 1 ; full details can be found in Table S2 , and case reports can be found in the Supplemental Note). Most affected children were born after unremarkable pregnancies, at or near term, with a birth weight within the normal range, and they did not require neonatal resuscitation, although around half required hospitalization after birth because of jaundice, seizures, laryngomalacia, or cardiac problems. More consistent difficulties emerged in early infancy: hypotonia (noted in 11/12 subjects) was frequently evident, and it later manifested as motor delay and sometimes persistent problems in walking. Mild to moderate developmental delay was universal, and older children had ID which ranged from mild (two cases) to moderatesevere (two cases); most were in the moderate range (five cases). Most children attended schools for special educational needs, but one had mainstream education. Behavioral symptoms were prominent: seven of ten of the older individuals had formal diagnoses of autism spectrum disorder (ASD) and/or attention deficit hyperactivity disorder (ADHD). The head circumference was normal except in one subject, who had mild macrocephaly (þ2.21 standard deviations [SD]); magnetic resonance imaging (MRI) of the brain showed agenesis or thinning of the corpus callosum in four subjects, including the macrocephalic individual. Two individuals had seizures, but brain imaging was either normal or was not available. Three individuals had moderate-severe sensorineural hearing loss; ophthalmological abnormalities were frequent, including myopia (n ¼ 6), eyelid ptosis (n ¼ 2), and/or strabismus (n ¼ 4), and these were associated with marked visual impairment in two children. Congenital heart defects (CHDs) were present in six of the twelve subjects; the defects were classified 17 as left ventricular obstruction (n ¼ 3), conotruncal defects (n ¼ 1), and other (n ¼ 2). Present congenital gastrointestinal problems were ano-rectal abnormalities (n ¼ 2) and pyloric stenosis (n ¼ 1); two additional infants required feeding via gastrostomy tube. In later childhood, gastroesophageal reflux or episodic vomiting were significant management issues in four individuals. Facial dysmorphism was identified in 11 subjects; this was not characteristic, although arched eyebrows, epicanthic folds, prominent eyes, a prominent nasal tip or long columella, a long philtrum, wide or open-mouth posture, prognathism, and low set and prominent ears were highlighted in two or more subjects ( Figure 3 and Table S2 ). The subjects' stature was within the normal range except in one individual, who had mild short stature (À2.53 SD). Apart from the metopic synostosis present in the index individual, no other individuals had craniosynostosis.
We assessed the probable effects of the eight individual amino acid substitutions on the CDK8 kinase domain by examining available protein structures (Figure 4) . Three of the substitutions (c.79G>C [p.Val27Leu], c.85C>G [p.Arg29Gly], and p.Gly30Ser) are clustered in the Glyrich loop (amino acids 27-35), a highly conserved protein-kinase motif with a critical role in ATP binding and in the phosphoryl-transfer reaction. [21] [22] [23] Substitutions within this motif affect kinase activity and, in other kinases, have been described as pathogenic mutations responsible for various congenital disorders. 15, 22, 24, 25 Within the three-dimensional structure, all CDK8 substitutions either affect amino acids surrounding the ATP-binding pocket ( Figure 4B ) or are in contact with key functional amino acids; for example, the p.Ile223 residue is not directly part of the ATP-binding site but is within interacting distance of p.Lys153, which directly binds to the ATP phosphate in the input structural model. The recurrently mutated p.Ser62 residue is located in the aC-helix, 26 the conformation and interactions of which are important for CDK8 activity. 27 Two substitutions, c.533G>A To gain further insights into the effects of the mutations, we conducted molecular-dynamics simulations for wild-type (WT) and two selected CDK8 substitutions, p.Ser62Leu, and p.Arg178Gln, in complex with cyclin C and in the presence of ATP. The overall CDK8 protein structure and organization was predicted to be unchanged in the mutant models compared to in the WT. However, we found that in addition to impacting the ATP-binding site, the mutants were also predicted to induce pronounced structural changes in the substrate-binding site ( Figure 4C ). In particular, the substrate-binding site of the WT CDK8 protein can adopt more open conformations than its mutated counterparts, potentially allowing substrates to bind more closely in the vicinity of ATP in the WT protein.
To determine whether the CDK8 kinase domain substitutions had caused structural changes and/or affected the ability to bind ATP, we purified CDK8 kinase Modules that were isolated from cells by immunoprecipitation after the expression of WT or mutant-tagged-CDK8 (Figures 5A and S1), and we recorded protein-melting curves in the absence or presence of ATP ( Figure 5B ). In the absence of ATP, the thermal stability of mutant proteins ranged from indistinguishable to increased in comparison to the WT protein. Moreover, the stability of most mutant proteins was increased by the addition of ATP, in some cases to a greater extent than occurred in the WT protein.
Together these results suggest that none of the substitutions cause gross mis-folding of the protein, and most or all are still able to bind ATP.
Finally, we investigated how the CDK8 substitutions affected the kinase activity by measuring phosphorylation of one of its well-validated targets: p.Ser727, of the human transcription factor STAT1. [30] [31] [32] [33] [34] We used a CRISPR-Cas9-engineered human cell line (SW620 colorectal carcinoma cells) that lacks both CDK8 and CDK19 (M.J. Ortiz-Ruiz et al., Cancer Res., abstract). These cells exhibited baseline STAT1-Ser727 (pSTAT1) phosphorylation that was substantially increased when WT CDK8 was transiently re-expressed ( Figure 6 ). We performed site-directed mutagenesis to introduce the eight observed variants into CDK8 cDNA (Supplemental Material and Methods), which we transfected into the CDK8 and CDK19 CRISPR double-knockout cells. We observed that the cellular levels of pSTAT1 were reduced to a statistically significant extent, compared to WT, in all mutant-transfected cells ( Figure 6 ). For most mutants, the reduction in kinase activity was similar to that in the catalytically inactive CDK8 kinase-dead (p.Asp173Ala) mutant we used as a control, but in two mutants (p.Phe97-Leu and [c.669A>G] p.Ile223Met), an intermediate level of phosphorylation ($63% and $51% in comparison to the WT, respectively), was observed. Collectively, our genetic and functional assessments provide strong evidence for a previously unrecognized (to our knowledge) clinical disorder caused by heterozygous missense substitutions located in the kinase domain of CDK8. All eight distinct mutations were shown to have arisen de novo from unaffected parents ( Table 1 ) and exhibited a similar combination of molecular characteristics. All clustered within the kinase domain ( Figure 2 ) and were concentrated around the ATP binding pocket ( Figure 4) ; none was associated with gross protein instability, and all retained the ability to bind ATP ( Figure 5 ). Finally, all exhibited attenuated kinase activity in a previously validated assay of STAT1-phosphorylation, although the magnitude of the effect was diminished for two substitutions (Figure 6 ), suggesting partial retention of activity in those cases. Of note, the CDK8 mutant proteins maintained their ability to bind cyclin C, similar to the ability of the kinase-dead mutant (Figures 5A and S1, and as previously described). 35 The CDK8 kinase-dead mutant was previously shown to form a stable Module, although the inactive kinase was unable to phosphorylate its targets. 35, 36 Concordant with these molecular observations was a relatively consistent phenotypic presentation (Figure 3 , Table 1 , Supplemental Case Reports, and Table S2 ). Hypotonia was usually evident in infancy and, in children old enough for assessment, learning disability was universal and most commonly classified as moderate; most but not all children were attending schools for special educational needs. Associated behavioral problems, which were frequent and added to the management issues for these children, included formal diagnoses of ASD and ADHD, sleep disorders, and episodic vomiting. Dysmorphic facial features, including arched eyebrows, a bulbous or upturned nose, and hypotonic facies, were frequent; however, these do not constitute a consistent or easily recognizable phenotype. Six of 12 subjects had congenital heart malformations, including at least three requiring corrective surgery. Additional medically significant features are documented in Table 1 . The high frequency of diagnosis of ASD, ADHD, and CHD in these children is of note because CDK8 mutations have not previously been highlighted in genetic screens of those disorders; 17, 37 this might be because the target size for mutations of CDK8 (missense substitutions surrounding the ATP-binding pocket) is relatively small. Although the mutation in our index subject, who had metopic synostosis, was originally identified in a genetic study of craniosynostosis, none of the 11 other subjects identified had this Figure 4 . Location and Effect of CDK8 Substitutions on the Protein Structure (A) Overall structure of CDK8 (light gray) in complex with cyclin C (dark gray). ATP (blue) was modeled into the CDK8 DMG-in crystal structure (PDB: 4F7S) 18 using aligned CDK9 (PDB 3BLQ). 19 Regions not previously resolved in the crystal structure have been modeled using Molecular Operating Environment (MOE). 20 (B) A magnified view of the catalytic region of the CDK8 kinase domain. The Mg 2þ is shown as a green sphere. Amino acids at which mutations have been identified are colored in orange (except Ser62 in red and Arg178 in yellow), and relevant, potential interaction partners in the input structure are shown as sticks. Ile223 is in close proximity (double-headed arrow) to the Lys153 involved in interaction with ATP-phosphate. Arg178 forms a hydrogen bond with Tyr32 (Gly-rich loop) and interacts ionically with the catalytic Asp151. (C) A magnified overlay of the wild-type (WT) and mutant molecular-dynamics simulations of CDK8 (light gray) in complex with cyclin C (dark gray) in the presence of ATP (blue spheres). The areas displaying the most pronounced structural differences within the substrate binding site are colored (blue: WT, red: p.Ser62Leu, and yellow: p.Arg178Gln).
phenotype. It is unclear whether the co-occurrence of the mutation and craniosynostosis is causally linked (potentially through the adverse effect of the mutation on brain development) 38 or is coincidental.
In more than two decades since CDK8 was first identified in independent studies of the yeast Saccharomyces cerevisiae (from screens for the stabilization of meiotic mRNAs [Ume5] 39 and suppression of an RNA polymerase II C-terminal domain mutation [Srb10]), 40 a large literature has accumulated about its functions. 5, 41 As described above and illustrated in Figure 1 , CDK8 encodes a kinase component of the Module, a four-subunit complex that binds to the Mediator and regulates its activity. Many fundamental uncertainties remain about its function, for example how the association and dissociation of the Module with the Mediator is regulated, how the Module regulates gene expression both positively and negatively, and the extent to which kinase activity per se is required for these functions. 2 Previous studies of human CDK8 have mostly focused on its potential as a therapeutic target in cancer, on the basis of the observation that amplifications of CDK8 are frequent in colon cancer. 42 Although effective CDK8 inhibitors have been developed, to date they have exhibited unacceptable toxicity. 31, 32 This toxicity might reflect the essential function of CDK8 for normal development, as shown by the pre-implantation lethality of homozygous-null Cdk8 mutations in the mouse; importantly in relation to the discussion below, heterozygous animals were reported to be normal and fertile. 43 If one focuses on the developmental role of CDK8, our observations show that although a single WT CDK8 allele is sufficient for survival, heterozygosity for a mutant allele that encodes a missense substitution of the kinase domain causes pleiotropic developmental abnormalities. Broadly speaking, heterozygous mutations might be associated with abnormal phenotypes through one of three mechanisms: haploinsufficiency, gain of function, and dominant-negative activity. 44 When haploinsufficiency occurs, many mutations are expected to be either truncating or partial or whole-gene deletions. Deletions involving CDK8 are very rare, and those recorded involve many other genes, so they are essentially uninformative. Although our gene-matching methods would not detect deletions, they were unbiased with regard to the nature of the intragenic mutation. It was previously reported that 381 of 706 de novo mutations in haploinsufficient genes were truncating, 11 so the finding that 11/11
(excluding the index subject) intragenic nucleotide substitutions encode missense changes diverges significantly from a haploinsufficiency pattern (p ¼ 0.0004). Moreover, human CDK8 is only moderately constrained to loss of function (probability that the gene is intolerant to a loss of function (LoF) mutation (pLI) ¼ 0.38, gnomAD database); it has six (out of $250,000) bona fide truncating alleles listed in gnomAD, suggesting that such alleles exist at low frequency in the normal population. Overall, haploinsufficiency appears unlikely to be the underlying Figure 5 . Immunoprecipitation of CDK8 and Thermal Stability Assay (A) Lysates from HEK293T cells transiently transfected with Myc-FLAG-tagged wildtype (WT) or mutant CDK8 constructs were used for immunoprecipitation with anti-FLAG antibody or mouse IgG isotype control antibody. The immunocomplexes were purified with protein G magnetic beads. CDK8 was released by adding FLAG peptide, and an aliquot of the eluted fraction was saved for immunoblot analysis with anti-Myc or anti-cyclin C (CycC) antibodies.
(B) A thermal stability assay of the eluted fractions incubated in the absence or presence of ATP and heated individually at different temperatures (gradient between 50-82 C). Virtual blot views of results for WT and the mutants are shown. For each CDK8 construct, the red arrowhead indicates 50% reduction of the CDK8 signal compared to the signal at the lowest temperature.
mechanism that explains the CDK8-mutation-associated phenotype.
Instead, our experimental observations indicate that the mutations retain ATP binding yet lose or diminish the ability to phosphorylate a well-established substrate, STAT1. This might result from reduced ATP catalysis and phosphoryl-transfer and/or altered substrate binding resulting from reduced accessibility of the substrate-binding site predicted by the dynamic modeling ( Figure 4) . Notably, CDK8 (together with its paralog CDK19) are the only components of the Module with catalytic activity, so we predict that up to 50% of CDK8 modules could be present in a kinase-inactive, non-productive state. The consequence of this would then depend on the extent to which supply of the catalytically-active Module was rate-limiting to key cellular processes in particular developmental contexts. The notion that the supply of active Modules might frequently be limiting is supported by the observation that all six other genes encoding components of the human Module (CCNC, CDK19, MED12, MED12L, MED13, and MED13L) exhibit very strong constraint against loss-of-function variation (pLI ¼ 1, observed/expected scores 0-0.11), indicating that reduction of any Module component by 50% impairs survival (by contrast, only three of 26 genes encoding other components of the Mediator exhibit pLI ¼ 1; Table S3 ). Together, these observations currently support a dominant-negative mechanism of pathogenesis for CDK8 substitutions. Similar patterns of localized missense substitutions have been highlighted as a signature of dominant-negative activity, including in the kinase domain of another cyclin-dependent kinase, CDK13. 15, 16 Moreover, overexpression of the kinase-dead mutants of different CDKs (CDK1, CDK2, CDK3, or CDK9) in human cells was previously observed to act by dominant-negative mechanisms. [45] [46] [47] We explored the mechanism directly by mixing equal amounts of the WT and p.Ser62Leu CDK8 constructs and measuring STAT1 phosphorylation, but the observed reduction in phosphorylation in mixed samples did not obviously deviate from a linear response (data not shown); hence, further experiments will be required to support or refute the dominant-negative hypothesis.
Previous observations that mutations in MED12 (X-linked; mostly hemizygous) and MED13L (heterozygous) were associated with generally similar phenotypes, including ID, hypotonia, and other congenital anomalies, [6] [7] [8] 48 led to the coining of a so-called ''mediatorpathy'' phenotype. 49 More recently, heterozygous mutations in MED13 were also considered to fit this pattern. 9 Interestingly, in the case of MED12, it was demonstrated experimentally that the substitutions p.Arg961Trp and p.Asn1007Ser (causing FG and Lujan syndromes, respectively), exhibit impaired recruitment of CDK8 onto GLI3-target gene promoters, leading to hyperactivated GLI3-dependent SHH signaling. 50 Here, we find that the major clinical features (including moderate ID, hypotonia, ASD, ADHD, and CHD) associated with CDK8 mutations again show substantial phenotypic overlap, lending further support to the general concept of a Module-related syndrome. By contrast, relatively fewer (to date, up to four replicated: MED17, MED20, MED23, and MED25) mutations in the other 26 non-Module components of the Mediator have been described; bi-allelic mutations in MED17 or MED20 (both members of the Mediator's Head) produce progressive cerebral and/or cerebellar atrophy, whereas bi-allelic mutations in MED23 or MED25 cause syndromic or non-syndromic ID (summarized in Table S3 ).
In summary, therefore, our observations support the proposed clustering of developmental disorders related to perturbed function of the Module (''Mediator kinase modulopathy''). Given the pleiotropic actions of the Module, many mechanisms, including defects in key developmental signaling pathways, might lead to these pathologies. For example, the severe developmental defects identified in embryos with Med12 hypomorphic mutations are produced by impairment of the canonical and Wnt/PCP signaling pathways; 51 analogously, CDK8 has a pivotal role as a regulator of several additional signaling pathways, including WNT, TGFb/BMP, STAT1, SHH, and NOTCH. 52, 53 Thus, a disruption of the proper activity of CDK8 could modify any of these developmental signaling networks. Although the idea of a Mediator kinase modulopathy as a pathogenic entity is attractive, several cautions are necessary. Genetic evidence from Drosophila formally demonstrates the non-equivalence of different Module components, on the basis of differences in the respective phenotypes when comparing mosaic knockouts for a Cdk8-Ccnc pair compared with a Med12-Med13 pair. 54 This situation is compounded for vertebrates, in which paralogous pairs exist for three of the four Module subunits. Indeed, the single described disruption (caused by a chromosomal inversion) of the CDK8 paralog CDK19 was associated with a different phenotype that comprised microcephaly, congenital bilateral falciform retinal folds, nystagmus, and learning disability; 55 however, the functions of CDK8 and CDK19 are known to be divergent. 56 Finally, it remains uncertain to what extent, and in which circumstances, Module activity might be kinase-independent because these functions would likely be unaffected by the mutations described here. 2 Further work on the structure and function of the Mediator will doubtless shed light on these issues. Figure 6 . Effect of CDK8 Substitutions on STAT1-Ser727 Phosphorylation SW620 CDK8 and CDK19 double-knockout cells were transiently transfected with FLAG-tagged wild-type (WT) or mutant CDK8 constructs, and the cellular levels of pSTAT1-Ser727 were determined as a readout of CDK8 activity. The CDK8 kinase-dead (p.Asp173Ala) mutant was used as a control for defective kinase activity. Whole-cell lysates from non-transfected cells (E lane) or from transfected cells were collected, and equal amounts of total protein were subjected to immunoblotting with anti-phospho-STAT1-Ser727 and anti-STAT1 (total) antibodies. Anti-FLAG was used to detect the overexpressed CDK8 constructs, and GAPDH was used as loading control. Representative blots are shown in the two left panels. For the quantification (right panel), the relative intensities of the bands were taken as a ratio of the phosphorylated STAT1-Ser727 (pSTAT1) over the total amount of STAT1 (STAT1) The HDAC9 NM_178423.1:c.646C>T (p.Arg216*) variant is not present in gnomAD.
Although it was suggested that HDAC9 deletions could represent a risk factor for autism, ID and schizophrenia associated with incomplete penetrance/variable expressivity, 2 the involvement of HDAC9 mutations in congenital disorders has not been defined.
Subject 2
This 3-year old male was born at 37+5/7 weeks by forceps-assisted vaginal delivery after an uncomplicated pregnancy. Apgar scores were 7 and 8 at 1 and 5 min, respectively. The neonatal course was significant for respiratory distress thought to be secondary to meconium aspiration, hyperbilirubinemia requiring phototherapy, and feeding difficulty. He did not pass his newborn hearing screen, which was initially thought to be related to antibiotics given as part of sepsis rule-out during his neonatal intensive care unit (NICU) course. He went on to demonstrate significant delays in his development in all domains. An evaluation at 12-13 mo showed age equivalencies of 3-4 mo for gross and fine motor skills, and 6-7 mo for social development. At the most recent assessment (aged 3 yr)
he was able to roll and hold his head up, as well as sit propped up in a chair but not unsupported. He could reach for toys and grasp with a full hand but had no pincer grasp. He says "mama" and "papa" but no other words, he responds to his name and tracks well. On general examination he is dysmorphic with brachycephaly and a tall and broad forehead, shallow orbits with the appearance of proptosis, low set ears with overfolded superior helices bilaterally and a tented mouth that is held open (low facial tone). His growth parameters are all within the normal range. Neurologic exam showed an alert toddler with no verbal output, good tracking and attention to sound. He was able to follow some simple commands from parents with prompting. He has marked global hypotonia with normal reflexes and no clonus, as well as frequent nonpurposeful complex stereotypic movements of his distal extremities.
He is currently followed by multiple specialties, including ophthalmology for nystagmus, high myopia, and optic nerve cupping of both eyes; neurology; audiology for sensorineural hearing loss; and an aerodigestive team for feeding (he now has a G tube in place for nutrition) as well as respiratory concerns. He no longer requires oxygen and has had some improvement in swallowing, however aspiration continues to be a risk. He has had a normal echocardiogram.
As part of his diagnostic work-up, trio whole exome sequencing was performed by GeneDx, which identified a de novo missense variant of uncertain significance in the gene CDK8 (c.85C>G, p.Arg29Gly).
Subject 3
This 9-year old boy was born as the second child, after an uneventful pregnancy of non-consanguineous parents, with a severe trigonocephaly, a perimembranous ventricular septal defect with a double orifice mitral valve, and pyloric hypertrophy for which surgery was required. Measurements of thyroid function were normal. No intracranial anomalies were seen on the preoperative CT scan and an ultrasound of the kidneys was normal. An uneventful fronto-supraorbital reconstruction was performed at 10 mo.
His development was delayed and he started walking at age 2.5 yr and talking at age 4 yr. At 8 yr an IQ of 55 was measured; his social behavior was like a 12-to 18-month old. He had trouble going to sleep for which melatonin was used. The diagnosis of autism spectrum disorder (ASD) and of ADHD was made; the ADHD worsened in response to Ritalin and was thus stopped. On ophthalmological review he had intermittent exotropia and surso adductorius in both eyes with V-motility. Vision was 0.5 for both eyes but somewhat unreliable due to a lack of concentration.
Whole genome sequencing (WGS), performed on the parent-child trio as part of a research study of craniosynostosis, did not identify any known pathogenic variants.
Three de novo substitutions were identified, of which the c.88G>A (p.Gly30Ser) mutation in CDK8 was selected for further investigation. in Ehlers-Danlos syndrome, 3 we cataloged this as a VUS.
Subject 4
This girl, currently aged 7.6 yr, was born to a 38 year old G2 P1 mother. The pregnancy was complicated by pneumonia, for which she took antibiotics. The prenatal ultrasound revealed a hypoplastic left heart and agenesis of the corpus callosum. She was born by caesarean section at 38 weeks' gestation, and was small for gestational age (birthweight 2.3 kg, length 47 cm). She was cyanotic and hypoxic at birth, and underwent cardiac surgery at 4 days of age via a Norwood procedure. She has subsequently undergone two additional cardiac surgeries, a bi-directional Glenn procedure aged 4 mo and a Fontan procedure aged 4 yr. She had dysphagia requiring a gastrostomy tube aged 7 mo, but now eats completely by mouth. She wears glasses for myopia and has normal hearing. A brain magnetic resonance imaging (MRI) confirmed agenesis of the corpus callosum and mild ventriculomegaly.
She has a history of failure to thrive and remains small for her age, with her height at -2.53 SD, weight at -1.92 SD, and a normal occipito-frontal circumference (OFC). She is mildly dysmorphic, with bilateral epicanthal folds, prominent eyes, a small nasal tip with a short columella and a broad nasal base, broad thumbs and broad, laterally deviated great toes, hypoplastic distal phalanges of all toes, planovalgus feet, and mild hypotonia.
Her development has been globally delayed. She did not roll or sit until 18 mo, walked at 4 ½ yr, said her first word at 4 yr, and spoke in sentences at 6 yr. She is in special education classes at school and receives speech, physical, occupational, developmental and music therapies. She has ADHD, with a sweet personality, but is sometimes aggressive, and has a severe sleep disorder.
Clinical WES was performed on the parent-child trio by GeneDx and did not identify any known pathogenic variants; however the de novo c.185C>T (p.Ser62Leu) substitution in CDK8 was reported as a VUS and submitted to GeneMatcher.
Subject 5
This individual is a 2-day old boy born after an uneventful pregnancy at 41+0 weeks' gestation via vaginal delivery after induced labor. He is the second child of unrelated parents. At birth he weighed 3120 grams. He was born with an ano-rectal malformation, an atrial septal defect, ventricular septal defect (VSD), bicuspid aortic valve, and a hypoplastic aortic arch. On examination no dysmorphic features were present except for low-set ears, which were slightly rotated backwards. He was lost to follow-up at the age of 6 mo, at which time he was unable to sit independently.
SNP-array showed a paternally inherited duplication at 7q11. congenital disorders is not well defined so far. A de novo LoF (frameshift mutation located in the last exon of the TRAF6) was described in one proband with hypohidrotic ectodermal dysplasia, 4 whereas a homozygous deletion affecting the 5′UTR of TRAF6
was recently identified in a subject with an atypical form of osteopetrosis. 5 We cataloged the identified variant as a VUS.
Subject 6
This individual is a 10 mo female, born to white parents aged 28 yr (mother) and 39 yr (father), and was initially referred for clinical genetics evaluation at the age of 5 mo owing to agenesis of the corpus callosum, aortic coarctation and global developmental delay. She has one healthy older sister. The mother had two previous miscarriages.
On examination she had a large head (occipito-frontal circumference [OFC] 47.5 cm, +2.21 SD), with hypertelorism, sparse eyebrows, long columella and downturned corners of the mouth, with axial hypotonia and hypertonia of the lower extremities.
Initial workup included a normal karyotype and SNP array. She underwent aortic coarctation repair aged 5 mo with a good result. When she was last evaluated at the age of 10 mo she had made some developmental progress, but was significantly delayed with milestones equivalent to 5 mo (rolling over, sitting with support).
Clinical WES was performed on the parent-child trio by GeneDx and did not identify any known pathogenic variants; however the de novo c.185C>T (p.Ser62Leu) substitution in CDK8 was highlighted as a VUS and submitted to GeneMatcher.
Subject 7
This male subject is the only child of his parents. At birth he was noted to have low set ears, redundant skin in the neck, lymphedema of the hands and feet, undescended testes, and echocardiography showed tetralogy of Fallot. An initial diagnosis of Noonan Syndrome was proposed. He underwent cardiac surgery at 9 mo. Assessment at 7 mo demonstrated mild delay of motor development and he continued to have low muscle tone throughout childhood. By 8 yr he had developed complex partial seizures and migraines, both improved with valproic acid. He had mild-moderate ID and was in special educational classes.
Genetic testing including array-comparative genomic hybridization (array-CGH), CHD7 and KAT6B did not reveal any pathogenic mutations.
Assessment at the age of 16 yr demonstrated persistence of low muscle tone, including low oral muscle tone with dribbling. He had an abnormal narrow palate with marked dental decay. He has had bilateral lateral column lengthening and serial plaster casting for pes planus and can walk for approximately 2 miles. He is registered as partially sighted due to a severe myopia. He attended school for children with special educational needs. At the age of 22 yr he was given a diagnosis of childhood autism.
He was enrolled as a singleton into the Deciphering Developmental Disorders (DDD) WES project, which did not identify any pathogenic variants of known clinical significance. The heterozygous c.185C>T (p.Ser62Leu) variant in CDK8 was identified through DDD CAP#144 and subsequently confirmed on dideoxy-sequencing to be present in the subject and absent in his mother. The father was unavailable for analysis.
Subject 8
This child is the second of two boys born to unrelated parents. The older brother has epilepsy but no other medical problems. The father (who was not available for genetic testing) is well; the mother, who has moderate learning difficulties, tested negative for the CDK8 c.185C>T variant identified in her son; there is no other family history of learning problems.
He was born after an uneventful pregnancy at 41 weeks' gestation with a birth weight At the age of 5.5 yr he was reviewed in the genetics clinic. He still had mild plagiocephaly. Hypotonia was improving; he had significant generalized joint laxity.
Aged 7 yr he had a microarray which showed a maternally inherited duplication at Xq21.31 (chrX:86315153-86578362; hg18) containing no RefSeq genes within the minimum region and considered to be an innocent finding.
At the last genetic review aged 12.7 yr his problems were global developmental impairment, ASD and ADHD, dysmorphic features and plagiocephaly, absent corpus callosum, generalized hypotonia, gastro-esophageal reflux with food regurgitation, recurrent loose stool and intermittent rectal mucosal prolapse, strabismus (wears corrective glasses). His height and weight were between the 2 nd and 9 th centile. He is regularly seen by the child adolescent mental health service. He attends a SEN school and due to social issues he is a child in care.
He was enrolled as a singleton into the DDD project, which did not identify any pathogenic variants of known clinical significance. The heterozygous c.185C>T
(p.Ser62Leu) variant in CDK8 was identified through DDD CAP#144 and subsequently confirmed on dideoxy-sequencing to be present in the subject and absent in his mother.
Subject 9
She is the 5 th child of healthy, unrelated parents and was born at term following a normal pregnancy. She first came to medical attention at a few days of age with paroxysmal events consisting of eye rolling and limb jerking. These events were captured during an electroencephalogram (EEG) recording and were not felt to be epileptic. She had failed her neonatal hearing screen and was diagnosed with sensorineural hearing loss; profound on the right and moderate on the left. MRI brain examination at the time was normal other than some hippocampal asymmetry. Array-CGH was normal. She was enrolled with her parents into the DDD and 100,000
Genomes (WGS) projects, neither of which identified pathogenic variants of known clinical significance. The de novo c.291T>G (p.Phe97Leu) variant in CDK8 was identified through DDD CAP#144.
Subject 10
He was born at term following an unremarkable pregnancy. He is the third child of healthy unrelated parents. He had mild hyperbilirubinemia as a baby that did not require any treatment. There were no developmental concerns prior to the age of 1 year. were confirmed by analysis of 13 microsatellite markers.
Subject 11
This girl is the first child born to healthy, unrelated Sri Lankan parents. There was no family history of note. The pregnancy was uncomplicated. Birth weight was 2.6 kg at 38 weeks' gestation. She was readmitted at 1 week of age because of hyperbilirubinemia, which needed treatment with phototherapy and an exchange transfusion. This was attributed at the time to breast milk jaundice. She was noted to have a laryngeal stridor early in life; this resolved spontaneously after 1-2 yr. She was delayed in reaching her milestones, sitting at around 9-10 mo, and walking at around 18 mo. She learned to ride a bike with stabilizers at the age of 6 yr.
At the age of 3 yr she developed cyclical vomiting. This problem has persisted, and aged 12 yr she continues to be treated with flunarazine. She also takes salbutamol as required for treatment of asthma. She has had grommets inserted on two occasions for bilateral glue ear.
Academically she is making reasonable progress, with a particular strength in reading.
She has an excellent memory. At school she is good at history, geography and English literature, but struggles in maths. She does have some specific learning difficulties; at the age of 12 yr she is unable to draw a straight line using a ruler, and has difficulties drawing a table or graph. These skills are felt to be around 5 yr behind her chronological age.
She is described as having a volatile personality. She can become easily disappointed if her requests are not met, and can be verbally aggressive at times; this tends to occur at home and be directed towards immediate family. At other times she is described as being sweet and charming. She can be overtalkative; non-verbal clues are often not understood. Anxiety can be an issue. Whilst she is not particularly hyperactive, and her attention span is reasonable when undertaking leisure activities such as reading, she is described as having some features compatible with ADHD. When she was younger her sleep was very restless, but she now sleeps well, although struggles to wake in the morning.
Socially, she has several long term friends. She loves small babies and wants to be a kindergarten teacher.
She was enrolled with her parents into the DDD (WES) project, which did not identify any pathogenic variants of known clinical significance. The de novo c.578T>G
(p.Val193Gly) variant in CDK8 was identified through DDD CAP#144.
Subject 12
This boy, a 3.5-year-old Armenian/Caucasian male, was referred for clinical genetics assessment secondary to history of hypotonia. His parents initially became concerned during the first year of life owing to delay in achieving his gross motor milestones. As an infant he was bottle-fed because of inability to latch onto the breast, but otherwise he had no feeding difficulties and weight gain was satisfactory.
He had been followed by the cardiology team secondary to a VSD, which has not required any surgical repair. His last echocardiogram, performed at the age of 6 mo showed one small 2 mm mid-muscular VSD and a second tiny anterior muscular VSD.
He has passed his vision screening in his primary care physician's office, and his newborn hearing screen. A more recent hearing evaluation was non-contributory owing to lack of co-operation.
He was diagnosed with autism aged 3 yr by his school psychologist and is currently Lysates from HEK293T cells transiently transfected with Myc-FLAG-tagged WT or mutant CDK8 constructs were used for immunoprecipitation using anti-FLAG antibody or mouse IgG isotype control antibody. The immunocomplexes were purified using magnetic beads with protein G. CDK8 was released by adding FLAG peptide and an aliquot of the eluted fraction was analyzed by automated capillary immunoassay system to detect CDK8, cyclin C, MED12 and MED13 (virtual blots at the top; relative quantifications from this experiment below). 
Supplemental Material and Methods

Exome/genome sequencing and validation
Trio whole genome sequencing of Subject 3 was performed by Complete Genomics (Mountain View, CA, USA), as described by Drmanac et al. 6 Data were analyzed using cga tools version 1.6.0.43. A de novo disease model was tested, using the 'calldiff script' (Python script kindly provided by Complete Genomics) as described by Gilissen et al. 7 Prioritization of variants was based on the minimal somatic score and manual curation of the variants.
Trio exome sequencing of Subjects 1 and 5 (Utrecht cases) was performed as follows:
exomes were enriched using the SureSelect XT Human All Exon V5 kit (Agilent) and sequenced in rapid run mode on the HiSeq2500 sequencing system (Illumina) at a mean target depth of 100x. The target was defined as all coding exons of UCSC and Ensembl +/-20 bp intron flanks. At this depth ~95% of the target was covered at least 15x. Reads were aligned to hg19 using BWA (BWA-MEM v0.7.5a) and variants were called using the GATK haplotype caller (v2.7-2). Detected variants were annotated, filtered and prioritized using the Bench NGS Lab platform (Cartagenia, Leuven, Belgium). Analysis was based upon a tiered approach. The first tier analyzed known intellectual disability genes. The second tier filtered for de novo variants and the last tier filtered for recessive variants. bp or greater paired-end reads. Reads were aligned to human genome build GRCh37/hg19, and analyzed for sequence variants using a custom-developed analysis tool. Additional details of the sequencing technology and variant interpretation protocol have been described previously. 8 The general assertion criteria for variant classification are publicly available on the GeneDx ClinVar submission page.
Exome sequencing of Subjects 7, 8 and 10 (as singletons), and 9 and 11 (as trios) was performed as part of the DDD research study. 9 Variant data were obtained as part of the approved Complementary Analysis Project #144 from Datafreeze 3, comprising 7,833 trios and 1,792 singletons with undiagnosed developmental disorders, primarily developmental delay/learning disability.
All the CDK8 variants were validated by dideoxy-sequencing of the probands, and all available parental samples were analyzed by exome/genome and/or dideoxysequencing to assess inheritance of the CDK8 mutations. In subject 10, in whom the Q17IE8), C. elegans (nematode worm; P90866), and the human CDK19 protein sequence (Q9BWU1), the vertebrate paralogue of CDK8, 10 were downloaded from Uniprot and a multiple protein sequence alignment was conducted by using Clustal Omega to evaluate the conservation of the CDK8 residues mutated in the subjects of this study.
Structure preparation
A homology model of CDK8 and cyclin C was generated in MOE 2015.10 11 using the CDK8-cyclin C complex structure (PDB entry 4F7S) 12 as template and the Uniprot 13 sequence identifier P49336 (CDK8 isoform 1) and P24863 (cyclin C isoform 1) to fill in gaps in CDK8 and remove artificial N-terminal residues in cyclin C in the input structure for molecular dynamics simulation. The homology model was aligned to the CDK9 structure (PDB entry 3BLQ) 14 and ATP and Mg 2+ were copied into the CDK8 structure. The CDK8 complex (referring to the structure of CDK8 + ATP + Mg 2+ + cyclin C) was prepared using the default settings of the protein preparation wizard in Maestro release 2017-2. 15 Mutations were introduced using MOE.
Simulation
ATP topologies and parameters were generated using CGenFF webserver and cgenff_charmm2gmx.py python script (MacKerell lab webserver). The protein, solvent and ions were parameterized using the July 2017 update of the CHARMM36 force field 16 in GROMACS version 2016.4. [17] [18] [19] [20] [21] [22] [23] The simulations were performed in a cubic box with a minimum distance to the box boundaries of 10 Å, solvated with TIP3P 24 waters and neutralized with chloride ions. After minimization, the system was equilibrated with 100 ps runs using both NVT and NPT ensemble where N = 138057 (CDK8 complex WT), 138059 (CDK8 complex p.Ser62Leu), 138055 (CDK8 complex p.Arg178Gln); T= 300 K; and P = 1 bar. Production simulations were run at least twice for 50 ns. If the variation between runs was large, a third run was included. Time steps of 2 fs were used and frames were saved every 10 ps. Temperature and pressure were maintained at 300 K and 1 bar and controlled by modified Berendsen thermostat 25 and the Parrinello-Rahman 26 barostat. The LINCS 27 and Particle-Mesh Ewald 28 algorithms were applied to define bond parameters and long-range electrostatics. A radius cut-off of 12 Å was applied to short-range van der Waals and electrostatic terms. The analysis was performed using the GROMACS analysis tools (rms, distance, hbond, covar, and anaeig) and figures were created using PyMOL. 29 
Expression constructs
The pCMV6-CDK8-Myc-FLAG (Origene, RC212592), containing the human cDNA open reading frame of human CDK8 (CDK8 WT) with C-terminal Myc-FLAG tags, was used for the functional analysis. The mutations in CDK8 were generated by mutagenesis PCR using the primers listed in the Table S5 and following the Q5-Mutagenesis kit protocol (New England Biolabs). The previously described catalytically inactive CDK8 kinase-dead (p.Asp173Ala) mutant was used as control. [30] [31] [32] All constructs were verified by dideoxy-sequencing (R1, F2 and F3 primers in Table   S5 ).
Cell culture, transfection and immunoblotting
The generation and full characterization of the SW620 CDK8/CDK19 double-knockout cells will be described in detail elsewhere. 33 
Immunoprecipitation, elution and thermal stability assay
We previously showed that ligand binding to the Mediator kinases determined by biochemical assays with recombinant CDK8/CDK19 and cyclin C is not always recapitulated in intact cells, suggesting that the other components of the kinase module can influence CDK8 ligand-binding and activity. 30 Therefore we determined whether the CDK8 kinase domain substitutions had caused structural changes and/or affected the ability to bind ATP using whole kinase Module complexes isolated from 
